Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/9475
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.rights.license | openAccess | - |
dc.contributor.author | Nesic, Maja | - |
dc.contributor.author | Kamčeva T. | - |
dc.contributor.author | Bugarčić, Živadin | - |
dc.contributor.author | Petkovic, Marijana | - |
dc.date.accessioned | 2020-09-19T18:22:38Z | - |
dc.date.available | 2020-09-19T18:22:38Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1475-6366 | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/9475 | - |
dc.description.abstract | This work has been focused on testing the influence of two selected Pt(II) complexes cisplatin, Pt(NH3)2Cl2, and [Pt(dach)Cl2] on the activity of porcine pancreatic phospholipase A2 (PLA2). It has been assumed that this enzyme plays a role in carcinogenesis and that it could be a target in the tumour therapy. The results of this study show that both Pt(II) complexes inhibit the activity of the enzyme, though they bind to it in a different manner. While cisplatin interacts with the enzyme in an acompetitive manner, the stable interaction of [Pt(dach)Cl2] with PLA2 could not be detected under our experimental conditions. © 2013 Informa UK, Ltd. | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.source | Journal of Enzyme Inhibition and Medicinal Chemistry | - |
dc.title | Inhibitory effect of cisplatin and [Pt(dach)Cl2] on the activity of phospholipase A2 | - |
dc.type | article | - |
dc.identifier.doi | 10.3109/14756366.2012.666539 | - |
dc.identifier.scopus | 2-s2.0-84880057888 | - |
Appears in Collections: | Faculty of Science, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
10.3109-14756366.2012.666539.pdf | 973.11 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License